Linfoma de sistema nervoso central com comprometimento intra e extracraniano em paciente näo imunodeprimido: relato de caso e revisäo da literatura

Brasil, Alvaro Azevedo Vital; Colleoni, Gisele W. B; Borducchi, Davimar M. M; Oliveira, José Salvador Rodrigues; Alves, Antônio Correa; Villar, Rosângela Corrêa; Segreto, Roberto A; Kerbauy, José.
Rev. bras. clín. ter ; 24(5): 225-8, set. 1998. ilus, tab
Artículo en Portugués | LILACS | ID: lil-226137

Documentos relacionados

  1. Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case.
  2. Successful desensitization in a patient with recurrent anaplastic oligodendroglioma presenting with procarbazine-mediated anaphylaxis.
  3. [Molecular pathogenesis and therapeutic development of primary central nervous system lymphoma: update and future perspectives].
  4. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
  5. Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.
  6. Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity.
  7. [Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma].
  8. Late Effects Following Treatment of Hodgkin Lymphoma During Childhood and Adolescence. Results of the Hodgkin Lymphoma Late Effects Research Project.
  9. Treatment Options for Recurrent Primary CNS Lymphoma.
  10. High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.